Deltex Med Grp PLC - Holding(s) in Company
|
|
||||
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
||||
|
|
|
|||
|
1. Identity of the issuer or the underlying issuer |
Deltex Medical Group Plc |
|||
|
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
|
An acquisition or disposal of voting rights |
ü |
|||
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
|
An event changing the breakdown of voting rights |
|
|||
|
Other (please specify): |
|
|
||
|
3. Full name of person(s) subject to the |
Bottomley Family |
|||
|
4. Full name of shareholder(s) |
|
|||
|
5. Date of the transaction and date on |
|
|||
|
6. Date on which issuer notified: |
|
|||
|
7. Threshold(s) that is/are crossed or |
5%
|
|||
|
8. Notified details: |
||||||||||||||||
|
A: Voting rights attached to shares viii, ix |
||||||||||||||||
|
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
|
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
|
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
|
|
60,000,000 |
60,000,000 |
100,000,000 |
100,000,000 |
0 |
5.27% |
0 |
|||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
B: Qualifying Financial Instruments |
||||||||||||||||
|
Resulting situation after the triggering transaction |
||||||||||||||||
|
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
||||||||||||||||
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
|
Resulting situation after the triggering transaction |
||||||||||||||||
|
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
|
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|
|||||||||||||||
|
|
||||||||||||||||
|
Total (A+B+C) |
||||||||||||||||
|
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
|
100,000,000 |
5.27% |
|||||||||||||||
|
9. Chain of controlled undertakings through which the voting rights and/or the |
||
|
|
||
|
|
||
|
Proxy Voting: |
||
|
10. Name of the proxy holder: |
|
|
|
11. Number of voting rights proxy holder will cease |
|
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
|
||
|
|
|
|
|
14. Contact name: |
H S Bottomley |
|
|
15. Contact telephone number: |
07774444134 |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).
Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.
Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.
All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.
This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.
This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.
FOR OUR FULL DISCLAIMER CLICK HERE